Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/8598
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVlachoyiannopoulos, P. G.en
dc.contributor.authorPetrovas, C.en
dc.contributor.authorTzioufas, A. G.en
dc.contributor.authorAlexopoulos, C.en
dc.contributor.authorTsikaris, V.en
dc.contributor.authorGuialis, A.en
dc.contributor.authorNakopoulou, L.en
dc.contributor.authorSakarellos-Daitsiotis, M.en
dc.contributor.authorSakarellos, C.en
dc.contributor.authorDavaris, P.en
dc.contributor.authorMoutsopoulos, H. M.en
dc.date.accessioned2015-11-24T16:42:48Z-
dc.date.available2015-11-24T16:42:48Z-
dc.identifier.issn0896-8411-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/8598-
dc.rightsDefault Licence-
dc.subjectsystemic lupus-erythematosusen
dc.subjectt-cellen
dc.subjectantigenic peptidesen
dc.subjectnuclear antigensen
dc.subjectantibodiesen
dc.subjectautoantibodiesen
dc.subjectidentificationen
dc.subjectautoimmunityen
dc.subjectpolypeptideen
dc.subjectautoantigenen
dc.titleNo evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs)en
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondary<Go to ISI>://000085065900007-
heal.identifier.secondaryhttp://ac.els-cdn.com/S089684119990344X/1-s2.0-S089684119990344X-main.pdf?_tid=170e70897d7b02013bfc7df078a8545e&acdnat=1333039015_da62339b5dafa9f36f5b2e48b4295734-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2000-
heal.abstractThe sequence Pro-Pro-Gly-Meth-Arg-Pro-Pro (PPGMRPP) is the major B-cell epitope of the Sm autoantigen. The aim of the present study was to evaluate the immune response against the native forms of Sm and U1RNP and immune mediated tissue injury after immunization with the sequence PPGMRPP anchored in five copies to a new type helicoid sequential oligopeptide carrier (SQC) formed by the repetitive Lys-Aib-Gly moiety, [(PPGMRPP)(5)SOC5]. Rabbits (n = 3) were immunized with 0.5 mg of (PPGMRPP)(5)SOC5 in complete Freud's adjuvant and boosted at days 26, 53, 99; control rabbits were immunized with the PPGMRPP alone (n = 3), phosphate buffered saline (PBS) (n = 1), SOC, alone (n = 1), a peptide at aminoacid (aa) position 158-177 of myelin basic protein (MBP aa 158-147) (n = 1) and three La/SSB autoantigen B-cell epitopes (n = 3). Antibodies to (PPGMRPP)(5)SOC5 were determined by enzyme linked immunosorbent assay (ELISA); precipitating anti-Sm and anti-U1RNP antibodies were detected by RNA precipitation and western blot on HeLa total cellular and nuclear extract and 12s sucrose gradient fraction of rat Liver extracts. High titres of anti-(PPGMRPP)(5)SOC5 antibodies not recognizing the native forms of Sm or U1RNP antigens were detected in the (PPGMRPP)(5)SOC5 immunized but not in the control animals. The sera of two (PPGMRPP)(5)SOC5 immunized but not of the control rabbits recognized a 67 kDa protein in HeLa nuclear extract, distinct from the 70 kDa U1RNP antigen. Diffuse and segmental increase of mesangeal matrix and cells, crescent formation, segmental glomerular necrosis, rarely massive subendothelial deposits occluding the lumen and C3 complement component in the mesangeal area were seen in the kidneys of one (PPGMRPP)(5)SOC5 immunized, but not of the remaining animals. In conclusion, the immune response induced by (PPGMRPP)(5)SOC5 was specific for the immunizing epitope but not for the native forms of Sm and U1RNP antigens, but it was associated with immune mediated kidney injury. (C) 2000 Academic Press.en
heal.publisherAcademic Press Ltd.en
heal.journalNameJ Autoimmunen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Files in This Item:
File Description SizeFormat 
Vlachoyiannopoulos-2000-No evidence of epito.pdf780.62 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons